About Us
Semorex is a privately held U.S. based development-stage company with an R&D subsidiary, Semorex Technologies Ltd., based in Israel. Our core competency and proprietary technology in Selective Molecular Recognition enables us to develop novel targeted therapeutics for patients with cancer and end-stage renal diseases.
These are markets with significant unmet needs and substantial growth potential. Semorex estimates that its lead product candidates have the potential to generate well in excess of $1 billion in revenues upon successful development.
|
|
